Landmark Publication Endorses Prana`s Strategy
Filed with ASX ·
6ix hasn’t read this filing yet.
Alterity Therapeutics Ltd. on 6ix
Earlier from Alterity Therapeutics
- Significant Promise in the Fight Against Alzheimers Disease
- Prana Receives Recommendation to Proceed with Clinical Trial
- Prana Provides Clinical Trials Update
- Prana Doses First Patient in the IMAGINE Phase II Trial
- Prana Comments on Neurology Publication Huntington Data
Later from Alterity Therapeutics
- PBT2 - Directly Restores Neurons Critical to Cognition
- Prana accelerates PBT2 commercial development
- Prana Raises A$6.19 million in a Private Placement
- Prana`s PBT2 Phase II trial receives funding from ADDF
- Quintiles Makes Second Investment in Prana
Follow Alterity Therapeutics into a list and get an email when it puts out news.
Follow Alterity Therapeutics